Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000353381

Medchemexpress LLC Thalidomide-O-PEG4-Boc | 2411681-87-1 | C28H38N2O11 | 100 MG
SDP

Catalog No. 5000353381
Encompass_Preferred

Thalidomide-O-PEG4-Boc is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide-based cereblon ligand and a linker used in PROTAC technology. This molecule is designed to exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.

  • E3 ligase ligand-linker conjugate
  • Incorporates Thalidomide-based cereblon ligand
  • Used in PROTAC technology
  • Exploits the intracellular ubiquitin-proteasome system
  • Selectively degrades target proteins
  • Targets E3 Ligase Ligand-Linker Conjugates, Apoptosis, and Autophagy
  • Targets Cereblon with an IC50 & Target affinity
  • Molecular weight of 578.61

Catalog No. 50-003-53381 Supplier Medchemexpress LLC Supplier No. HY141014100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Thalidomide-O-PEG4-Boc is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide-based cereblon ligand and a linker used in PROTAC technology. This molecule is designed to exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.

  • E3 ligase ligand-linker conjugate
  • Incorporates Thalidomide-based cereblon ligand
  • Used in PROTAC technology
  • Exploits the intracellular ubiquitin-proteasome system
  • Selectively degrades target proteins
  • Targets E3 Ligase Ligand-Linker Conjugates, Apoptosis, and Autophagy
  • Targets Cereblon with an IC50 & Target affinity
  • Molecular weight of 578.61

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.